Exploration of risk factors and characteristics of COVID-19 infection among patients with hematological malignancies in Suzhou, China: a retrospective study.

ABSTRACT:

Background and aim

Patients diagnosed with cancer, particularly those with hematologic malignancies, frequently exhibit a state of immunosuppression. Currently, there remains a scarcity of dependable biomarkers for assessing the severity of COVID-19 in individuals with hematologic malignancies. We conducted a retrospective study of morbidity and mortality in patients with hematological malignancies (HM) who had contracted COVID-19. The aim was to offer a reference for clinical diagnosis and treatment.

Methods

A total of 71 patients with HM-confirmed COVID-19 were enrolled from December 2022 to May 2023. Clinical symptoms, laboratory findings, and treatment approaches were collected and documented. Patients were classified into survival and death groups based on their COVID-1

SUBMITTER: Yao Y 

PROVIDER: S-EPMC11885061 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature